Manhattan Scientifics, Inc.'s Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram  
4/21/2010 10:01:35 AM

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics, Inc. (OTCBB: MHTX) announced today that its "early cancer detection" technology, developed by Edward R. Flynn, Ph.D. is expected to identify breast cancer three years earlier than the current gold standard mammogram test. Dr. Flynn is a pioneer in the emerging field of nano medicine.